Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Frontier Medicines Corporation
AstraZeneca
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
AstraZeneca
Bristol-Myers Squibb
Seagen Inc.
Genmab
Origin Sciences
Incyte Corporation
Seagen Inc.
Seagen Inc.
Servier
Eli Lilly and Company
Pfizer
Novartis
Fondazione del Piemonte per l'Oncologia
PMV Pharmaceuticals, Inc
Exelixis
Mayo Clinic
Mayo Clinic
Novartis
BioNTech SE
AstraZeneca
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
Kivu Bioscience Inc.
NeoImmuneTech
AstraZeneca
Alterome Therapeutics, Inc.
Verastem, Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Hoffmann-La Roche
EMD Serono
Guangzhou JOYO Pharma Co., Ltd
Qilu Pharmaceutical Co., Ltd.
City of Hope Medical Center
AstraZeneca
Aveni Foundation
Exelixis
Neonc Technologies, Inc.
Arcus Biosciences, Inc.
Erasca, Inc.
Sumitomo Pharma America, Inc.